CBAK Energy Technology, Inc. (LON:0A98)
London · Delayed Price · Currency is GBP · Price in USD 0.9090
+0.0132 (1.47%)
At close: Dec 11, 2025
CBAK Energy Technology Revenue
CBAK Energy Technology had revenue of $60.92M USD in the quarter ending September 30, 2025, with 36.51% growth. This brings the company's revenue in the last twelve months to $161.76M, down -22.02% year-over-year. In the year 2024, CBAK Energy Technology had annual revenue of $176.61M, down -13.61%.
Revenue (ttm)
$161.76M
Revenue Growth
-22.02%
P/S Ratio
0.49
Revenue / Employee
$110.57K
Employees
1,463
Market Cap
59.14M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 176.61M | -27.82M | -13.61% |
| Dec 31, 2023 | 204.44M | -44.29M | -17.81% |
| Dec 31, 2022 | 248.73M | 196.06M | 372.24% |
| Dec 31, 2021 | 52.67M | 15.10M | 40.21% |
| Dec 31, 2020 | 37.57M | 15.37M | 69.26% |
| Dec 31, 2019 | 22.19M | -2.24M | -9.16% |
| Dec 31, 2018 | 24.43M | -33.94M | -58.14% |
| Dec 31, 2017 | 58.38M | 50.01M | 597.49% |
| Dec 31, 2016 | 8.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |